GNS
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Genus plc is an animal genetics company that produces elite genetics and sells them to farmers, along with services to maximize their value. The company operates through two business units: ABS, focused on dairy and beef cattle, and PIC, focused on pigs. Customers access the company's genetics by purchasing live animals, semen, or embryos for use in their own breeding programs. Genus utilizes genomic selection to drive continuous genetic improvement in its herds, analyzing DNA to identify genetic markers linked to characteristics such as feed conversion efficiency, disease resistance, and growth rate. The company also develops proprietary technologies, including sexing technology that sorts semen into female and male sex. Genus serves customers across six continents and reaches additional markets through distribution partners. Its business model supports the dairy, beef, and pork food production sectors, helping farmers produce milk and meat more efficiently.

Summarised from the company's own disclosures, fiscal year ended Jun 2026

Industry Agricultural Inputs Homepage genusplc.com
Sector Basic Materials IR page genusplc.com/investors
Tags
animal genetics, bovine genetics, porcine genetics, genomic selection, semen, embryos, dairy cattle, beef cattle, pigs, breeding services, ABS, PIC
Press page genusplc.com/media-centre

Metrics

Valuation  
Market cap £ 1.414B
Market cap (USD) $ 1.898B
P/E 4.96
PEG 0.05
P/BV 1.84
P/S 2.15
P/OCF 19.01
P/FCF 22.85
Dividend yield —
Turnover / mcap —
Returns  
ROE 45.9%
ROI 33.8%
ROIC 9.5%
Profit margin 43.4%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 104.6%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 10.0%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 22.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Revenue 658.1M 672.8M 668.8M 689.7M 593.4M 574.3M — 488.5M 470.3M 459.1M 388.3M 398.5M 372.2M 345.3M 341.8M — — —
Net profit 285.5M 19.3M 2.4M 31.8M 36.7M 46.8M 40.9M 6.7M 41.6M 34.3M 50.3M 40.5M 28.9M 27M 39.6M 29.2M 275M —
Free cash flow 61.9M — — — — — — — — — — — — — — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Share price 21.4 24.75 18.12 24.37 45.46 56.18 — — — — — — — — — — — —
Price performance 12m -0.14 0.37 -0.26 -0.46 -0.19 — — — — — — — — — — — — —

Filed figures

Figure Jun 2021 Jun 2022 Jun 2023 Jun 2024 Jun 2025 Jun 2026
Balance sheet detail
Trade receivables (GBP) — 130M 132M 135M 119M 121M
↳ YoY growth +2.0% +2.3% -11.8% +1.4%
Borrowings, current (GBP) — 7.1M 4.2M 4.9M 2.9M 4.3M
Borrowings, non-current (GBP) — 182M 196M 228M 216M 77M
Lease liabilities (GBP) — 34.6M 31.9M 58.1M 47.1M 26.2M
Cash and deposits (GBP) 46M 38.8M 36.3M 42.5M 48M 43.7M
Intangible assets (GBP) — 72M 66.2M 65.4M 55.3M 49.5M
Net debt (borrowings + leases - cash) (GBP) — 185M 196M 249M 218M 63.8M
Cash flow detail
Operating cash flow (GBP) — -67.2M -30.9M 29.8M 67.2M 74.4M
Purchases of property, plant and equipment (GBP) — -42.1M -25.9M -14.8M -13.4M -12.5M
Purchases of intangible assets (GBP) — -8.8M -9.3M -9.9M -5.2M -5.6M
Dividends paid (cash effect) (GBP) — -20.9M -21M -21M -21.1M -21.7M
Share-based compensation (GBP) — 3.7M 6M 7M 6.9M 10.4M
Free cash flow (OCF - PPE - intangibles) (GBP) — -118M -66.1M 5.1M 48.6M 56.3M
Income detail
Total comprehensive income (GBP) — 92.5M 9.9M -17.8M -23.8M 304M
Comprehensive income to owners (GBP) — 97.3M 11.1M -12.3M -23.6M 304M
Reported Oct 13, 2023 Oct 13, 2023 Oct 13, 2023 Oct 14, 2024 Oct 17, 2025 Oct 9, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Admission to Trading Bull 0 Bear 0 Routine

10/14/2026

Download (opens in new window)

RNS Number : 8223Y

Genus PLC

14 October 2026

14 October 2026

Genus plc

Admission of Further Securities to Trading

The following additional information is disclosed in accordance with The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R. 

1 Details of the issuer
a) Name Genus plc
b) LEI 54930022EOITNKSIGH56
2 Details of the transferable securities admitted to trading
a) Name Genus plc
b) Type Ordinary Shares of GBP 0.10 each
c) Identification code ISIN: GB0002074580
d) Regulated market London Stock Exchange - Main Market
e) Number of further securities issued and admitted 451,551
f) Total number of securities in issue at date of notification 65,592,570 Ordinary Shares
g) Fungibility Fully fungible with existing Ordinary Shares
3 Admission details
a) Date of admission Admission of 450,000 new ordinary shares allotted to the Company’s EBT 6 October 2026 as announced on 30 September 2026.Admission of 1,551 shares allotted under the Company's employee share schemes between 28 September 2026 and 13 October 2026, admitted to trading on the Main Market of the London Stock Exchange under the Company's existing block admissions of shares dated 22 March 2023.
b) Prospectus details N/A

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com .

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy .

END

ADMMJBPTMTMBBFF

Close this window

Transaction in Own Shares Bull 1 Bear 0 Routine

10/12/2026

Download (opens in new window)

RNS Number : 4369Y

Genus PLC

12 October 2026

Genus plc

Transactions in own shares

In accordance with UKLR 9.6.6R, the Company announces that during the period from 5 October 2026 to 9 October 2026 it purchased through J.P. Morgan Securities plc a total of 357,646 of its ordinary shares of 10 pence each.

The purchased shares will be cancelled.

Aggregated information

Trade Date Number of ordinary shares purchased Lowest price paid per ordinary share (pence) Highest price paid per ordinary share (pence) Volume weighted average price paid per ordinary share (pence)
5 October 2026 88,740 2,130.0000 2,168.0000 2,149.5642
6 October 2026 61,753 2,102.0000 2,144.0000 2,131.0352
7 October 2026 85,780 2,122.0000 2,208.0000 2,176.9716
8 October 2026 84,184 2,188.0000 2,226.0000 2,207.7178
9 October 2026 37,189 2,242.0000 2,338.0000 2,312.1824

Disaggregated information

In accordance with UKLR 9.6.6R and Article 5(1)(b) of Regulation (EU) No 596/2014 (as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended), detailed information about the individual purchases is detailed in the link below:

http://www.rns-pdf.londonstockexchange.com/rns/4369Y_1-2026-10-9.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com .

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy .

END

POSFLFERIFLAIIR

Close this window

Prompts

Genus plc (ticker GNS), listed in United Kingdom.

ETFs Holding Genus plc

ETF Weight in ETF Shares Market value As of
DFIS 0.00% 7,625 $ 231.547K Nov 12, 2026
AVDS 0.00% 332 $ 10.19K Nov 16, 2026